|
|
 |
|
Viewing report
|
|
|
|
Indian Bulk Drugs
CYGNUS Business Consulting & Research, July 2008, Pages: 183
Introduction
The Indian API (bulk drugs) manufacturing industry is estimated to have touched USD4.10 billion by 2007, growing at CAGR of 18.81% during 2003-07. India ranks fourth in terms of volume among the top 15 drug manufacturing countries. Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight to capture the present domestic market scenario, along with the major players and their key financials
Key Findings & Highlights
- The global pharmaceutical market was valued at USD712 billion in 2007.
- According to IMS Health, treatment costs per day declined by 20-40% in 2007 in therapy Areas
- Generics continued to replace branded prescriptions in the major therapeutic classes, increasing their share of total dispensed prescriptions to 67.3 %.
- In 2007, North America, which accounts for 45.9% of global pharmaceutical sales, grew by 4.2% to USD304.5 billion
- The market size for the global bulk drugs was USD77.32 billion in 2005 and was estimated to be USD92.21 billion in 2007
- Indian companies have the distinction of developing cost-effective technologies for manufacturing bulk drugs and intermediates that conform to global standards.
Reasons to Buy
- Understand the global bulk drug market scenario
- Know investment opportunities according to the trend analysis
- Reveals the demand analysis of the bulk drugs industry
- Assess the cost effective technologies for manufacturing bulk drugs
Indian Bulk Drugs
Given the significant export potential of the Indian bulk drugs industry, the latest version of the Indian Bulk Drugs Industry Insight has been released to capture the present domestic market scenario, along with the major players and their key financials. This report consists of 10 chapters. The overview of global bulk drugs market provides bulk drugs market size (2003–2007), segmental market size, the major players, and mergers and acquisition. It is followed by overview of Indian bulk drugs industry, which provides broad overview of the industry. The report then moves on to discuss the industry regulations, the growth drivers, and issues and challenges. The report comprises the profiles of 20 leading bulk drugs manufacturers with their SWOT analysis and outlook. The industry’s critical success factors and future outlook are discussed to provide key inputs for understanding the industry.
Targeted Audience:
-Pharma Companies
-Bulk drug manufactureres
-Banks
-Students
Also available
Indian Bulk Drug Industry Insight
Customers who bought this item also bought
Indian Bulk Drugs
Analyzing the Indian Pharmaceutical Industry
Indian Bulk Drug Industry Insight
Indian Shipping Industry
Global Bulk Drugs Industry Report
Indian Pharmaceutical Industry: Issues and Opportunities
India - Commerce and Industry Competitive Advantage Analysis
Analyzing the Indian Retail Industry
|
|
|
|
